Analyst Expectations for Alpine Immune Sciences's Future
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 4 analysts have published their opinion on Alpine Immune Sciences (NASDAQ:ALPN) stock. The average price target is $16.75, implying an upside from the current price of $12.67. This average price target has increased by 19.64% over the past month.
August 31, 2023 | 1:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have a bullish outlook on Alpine Immune Sciences (NASDAQ:ALPN) with an average price target of $16.75, indicating a potential upside from the current price.
The bullish outlook from analysts is based on their research and understanding of the company's business. The average price target of $16.75 is higher than the current price of $12.67, indicating a potential upside. This could lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100